ArticleCanadian journal of public health = Revue canadienne de sante publique
Statin use in Canadians: trends, determinants and persistence.
Article in Canadian journal of public health = Revue canadienne de sante publique. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Hypertension in people with type 2 diabetes: Update on pharmacologic management.Canadian family physician Medecin de famille canadien · 2011Pooled it
- Predictors of cholesterol treatment discussions and statin prescribing for primary cardiovascular disease prevention in community health centers.Preventive medicine · 2016 · on this mapTrial
- Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.Journal of the National Cancer Institute · 2011Trial
- Coronary revascularisation in British Columbia: 25-year trends in volume and modality.General thoracic and cardiovascular surgery · 2026Article
- Statin Prescription Patterns Among Elderly Patients with Type 2 Diabetes: A Cross-Sectional Study in Lebanon.Drugs - real world outcomes · 2023Article
- Prescribing patterns of statins and associated factors among type 2 diabetes mellitus patients attended at Jugol General Hospital in eastern Ethiopia: A cross-sectional study.Frontiers in clinical diabetes and healthcare · 2023Article
- Under-prescription of medications in older adults according to START criteria: A cross-sectional study in Lebanon.Health science reports · 2022Article
- Prevalence and factors associated with lipid-lowering medications use for primary and secondary prevention of cardiovascular diseases among Malaysians: the REDISCOVER study.BMC public health · 2022Article
- Statin Prescription Patterns and Associated Factors Among Patients with Type 2 Diabetes Mellitus Attending Diabetic Clinic at Muhimbili National Hospital, Dar es Salaam, Tanzania.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022Article
- Body mass index impacts the choice of lipid-lowering treatment with no correlation to blood cholesterol - Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS).Diabetes, obesity & metabolism · 2018Article
- The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin.Drugs - real world outcomes · 2017Article
- Statin use and risk of multiple myeloma: An analysis from the cancer research network.International journal of cancer · 2017Article
- Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data.Clinical epidemiology · 2016Article
- Article
- Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis.BMC health services research · 2014Article
- Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: a population-based survey.BMC medical informatics and decision making · 2012Article
- Central versus peripheral cardiovascular risk in metabolic syndrome.Frontiers in physiology · 2012Article
- Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study.Heart (British Cardiac Society) · 2011Article
- Statin induced myopathy presenting as mechanical musculoskeletal pain observed in two chiropractic patients.The Journal of the Canadian Chiropractic Association · 2010Article
- Patterns and predictors of statin prescription in patients with type 2 diabetes.Cardiovascular diabetology · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRegular statin use is an important tool in chronic disease management, lowering cholesterol levels and reducing risk of cardiovascular disease (CVD). The objectives of this study are to describe statin use in Canada by comorbidity and lifestyle risk factors, and determine persistence in statin use.
methodsThe longitudinal National Population Health Survey, 1994-2002, is a random sample of the 1994 Canadian population and five interviews were conducted at two-year intervals. A total of 8,198 respondents, aged 20 in 1994, completed all five interviews. Information collected included demographic variables, medication use, CVD lifestyle risk factors, CVD, diabetes and hypertension.
resultsAge-adjusted rates of statin use increased from 1.6% to 7.8% over the period 1994-2002. Statin use was higher with increasing age, diabetes, BMI, physician visits, and insurance for prescription medication. Although persons with CVD were more likely to take statins than those without, by 2002 still only 32.7% of heart patients were taking statins. Statin use did not increase linearly with increasing numbers of CVD risk factors or comorbidities. Of the 441 persons reporting statin use in 2000, 74.6% were still taking them in 2002. People who completed their high school education were more likely to continue taking statins than those who did not complete high school.
conclusionWhile statin use increased over time, was associated with CVD and diabetes, and to a lesser extent with increased BMI, a substantive underuse in high-risk patients remains. Helping high-risk people to increase statin use continues to be a priority for health care professionals.
Indexed as
Identifiers
17985686PMC6976171What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.